查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016639

陰道吊帶市場報告：規模、佔有率、趨勢和預測（按類型、產品類型、尿失禁類型、最終用戶、地區分類，2026-2034 年）

Vaginal Slings Market Report Size, Share, Trends and Forecast by Type, Product Type, Type of Urinary Incontinence, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

2025年全球陰道吊帶市場規模為15億美元。預計到2034年，該市場規模將達到25億美元，2026年至2034年的複合年成長率（CAGR）為5.63%。目前，北美市場佔據主導地位，預計2025年市佔率將達到約42.0%。推動市場成長的主要因素是應力性尿失禁盛行率的上升，尤其是在老年女性族群。此外，微創吊帶手術技術的進步和生物相容性材料的改進，提高了患者的治療效果，並增強了外科醫生對此手術的支持，進一步促進了市場成長。同時，人們對骨盆底疾病的認知不斷提高，加上醫療成本的上升以及發展中地區獲得專業治療的機會增加，也正在擴大陰道吊帶的市場佔有率。

全球市場正受惠於泌尿外科高階培訓計畫的日益普及，這些計畫不僅改善了手術效果，也增強了臨床醫師對吊帶手術的信心。目前，治療應力性尿失禁(SUI) 的標準手術方法是植入中段尿道吊帶 (MUS)，通常簡稱為「吊帶」。該技術的臨床療效已被廣泛認可，據報導成功率接近 80%。這極大地推動了該手術的普及，並進一步增強了對吊帶相關產品的需求。此外，醫院和專科醫療中心正在投資先進的骨盆底復健技術，以支持術後護理並降低復發率。同時，一些已開發地區正在調整醫保報銷模式，以支持門診手術，從而改善醫療服務的可近性並降低醫患雙方的成本。人們對客製化網片和微創單切口吊帶的興趣也日益濃厚，這些技術可以縮短手術時間並加快康復。此外，陰道吊帶市場的一大趨勢是，由於醫療設備製造商和學術機構之間合作的加強，新吊帶設計的臨床檢驗正在加速進行。

在美國，女性人口老化以及促進新型吊帶材料快速上市的系統性監管流程正在推動市場發展。根據產業報告顯示，到2024年，美國百歲老人中女性將佔78%。未來30年，預計到2054年，美國百歲以上人口數將從約10.1萬人激增至42.2萬人。此外，門診手術中心在泌尿系統和婦科護理中的作用日益增強，使得吊帶手術在大型醫院之外也更容易獲得。同時，用於提高患者對尿失禁認知的宣傳活動的資金投入，有助於減少偏見，並促進早期療育。此外，私人醫療保險對中段尿道吊帶手術的覆蓋範圍擴大，也推動了市場需求。此外，電子健康記錄與泌尿外科和婦科診療的整合，簡化了病患後續觀察，並改善了長期治療效果的追蹤。最後，美國領先的醫療設備製造商對骨盆底健康領域創新的投資，正在促進形成更具競爭力和更靈活的市場環境。

陰道吊帶市場的發展趨勢：

應力性尿失禁（SUI）盛行率上升

應力性尿失禁）是陰道吊帶術的主要臨床適應症，其盛行率的不斷上升直接推動了市場擴張。老化、肥胖率上升和產後併發症是導致SUI發病率上升的最常見因素。停經後後荷爾蒙變化會進一步削弱骨盆底支撐結構，增加治療性介入的需求。一項行業調查顯示，13%接受尿動力學檢查的女性被診斷為“尿動力學壓力性尿失禁”，改變了治療策略。這凸顯了準確診斷和有效治療方法（例如陰道吊帶術）的重要性。隨著全球醫療保健系統向早期篩檢和診斷方向轉變，越來越多的女性成為手術治療（包括吊帶手術）的候選人。人們對尿失禁的認知不斷提高，以及社會歧視的減少（尤其是在都市區和半都市區），也推動了患者就診量的增加。臨床指引也支持這一觀點，這些指引更積極地推薦吊帶作為中度至重度病例的第一線手術治療方法，尤其是在保守治療無效的情況下。

子宮切除率及術後併發症率增加

在全球範圍內，子宮切除術數量的增加，尤其是在女性群體中，推動了陰道吊帶市場的成長。根據業界報告顯示，15至49歲女性中約有3.3%接受了子宮切除手術。由於支撐子宮的結構被切除，子宮切除術後患者常出現骨盆器官脫垂和膀胱功能障礙。這些併發症可能導致應力性尿失禁，因此，吊帶手術成為恢復尿功能的首選治療方法。在某些地區，例如亞太地區和拉丁美洲部分地區，子宮切除術仍然是治療子宮肌瘤、慢性骨盆疼痛和子宮內膜異位症等疾病的常見手段，而且由於保守治療選擇有限，有時會過早進行手術。這導致了諸如尿失禁症狀的手術干預增加等次生影響。醫院和門診手術中心發現，骨盆底修復手術的轉診病例正在增加。泌尿系統和婦科醫師通常會在全子宮切除術期間或之後，為預期會出現尿失禁的患者植入吊帶。這些治療方法的標準化以及對骨盆底健康的積極關注，是吊帶使用量穩定成長的促成因素。

微型吊索的技術進步與創新

吊帶設計和材料的技術進步正在顯著提高其應用率。這一趨勢對陰道吊帶市場的前景產生了積極影響。傳統的中段尿道吊帶術後恢復期較長，且有網片侵蝕及術後排尿困難等風險。新型迷你吊帶和單切口系統正在改變這一現狀。這些裝置能夠縮短手術時間、減輕術後疼痛並降低併發症風險，使其特別適用於門診和日間手術。 2025年6月發表的一項研究報告了用於治療女性壓力性尿失禁的Contasure-Needleless® (C-NDL)迷你吊帶。短期結果（6個月追蹤）顯示，主觀治癒率較高，超過54.17%的患者報告症狀「顯著」或「非常」改善。尿失禁嚴重程度評分也顯著降低，併發症發生率極低。本研究得出結論，C-NDL迷你吊帶是一種安全、有效且微創的短期治療壓力性尿失禁的方法。此外，固定機制的改進和無張力設計降低了手術操作的差異性，並改善了長期治療效果。外科培訓計畫正在擴展以涵蓋這些新技術，其在泌尿系統和泌尿系統婦科的應用也日益廣泛。在某些市場中，機器人輔助和影像引導吊帶置入術的出現進一步表明，創新如何持續提高手術效率和病人安全性。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球陰道吊帶市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 傳統陰道吊帶
  • 高級陰道吊帶

第7章 市場區隔：依產品類型分類

  • 阻塞孔側吊帶
  • 無張力陰道吊帶
  • 其他

第8章 市場區隔：依尿失禁類型分類

  • 應力性尿失禁
  • 急性尿失禁
  • 混合性尿失禁

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 門診手術中心
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • AMI GmbH
    • B. Braun SE
    • Betatech Medical
    • Boston Scientific Corporation
    • Caldera Medical
    • Coloplast Corp
    • Cousin Surgery
    • Promedon GmbH
    • UroCure
Product Code: SR112026A6068

The global vaginal slings market size was valued at USD 1.5 Billion in 2025 . The market is projected to reach USD 2.5 Billion by 2034 , exhibiting a CAGR of 5.63% during 2026-2034 . North America currently dominates the market, holding a significant market share of around 42.0% in 2025 . The market is fueled by the rising prevalence of stress urinary incontinence among women, particularly in aging populations. Besides that, advancements in minimally invasive sling procedures and improved biocompatible materials have enhanced patient outcomes and surgeon preference, thereby supporting market growth. Additionally, growing awareness of pelvic floor disorders, coupled with increased healthcare expenditure and improved access to specialized treatments in developing regions, are collectively augmenting the vaginal slings market share.

The global market is benefiting from the increasing availability of advanced urogynecological training programs, which improve surgical outcomes and clinician confidence in sling procedures. The standard surgical approach for managing stress urinary incontinence (SUI) currently involves the insertion of a mid-urethral sling (MUS), often referred to simply as a "sling." This technique is widely recognized for its clinical efficacy, with reported success rates nearing 80%, which continues to drive strong procedural adoption and reinforce demand for sling-related products. Moreover, hospitals and specialty centers are investing in upgraded pelvic floor rehabilitation technologies, supporting postoperative care, and reducing recurrence rates. Additionally, reimbursement models in several developed regions have shifted to support outpatient procedures, increasing accessibility and reducing costs for both providers and patients. There's also growing interest in patient-tailored mesh options and minimally invasive single-incision slings, which reduce operative time and enhance recovery. Besides, one of the growing vaginal slings market trends is that the increased collaboration between device manufacturers and academic institutions has resulted in faster clinical validation of newer sling designs.

In the United States, the market is driven by an aging women's population and a structured regulatory pathway that facilitates quicker adoption of novel sling materials. According to industry reports, women represent 78% of the centenarian population in the U.S in 2024. Over the next 30 years, the number of Americans aged 100 and above is projected to surge from approximately 101,000 to 422,000 by 2054. Apart from this, ambulatory surgical centers have expanded their role in urogynecological care, making sling procedures more available outside major hospitals. In addition to this, patient awareness campaigns around urinary incontinence are better funded, helping to reduce stigma and encourage earlier intervention. Furthermore, private health insurance often covers mid-urethral sling procedures, which increases demand. Additionally, integration of electronic health records with urogynecology practice has streamlined patient follow-up, improving long-term outcome tracking. Also, investments in pelvic health innovation by major U.S.-based medtech firms contribute to a more competitive and responsive market landscape.

VAGINAL SLINGS MARKET TRENDS:

Rising Prevalence of Stress Urinary Incontinence (SUI)

Stress urinary incontinence is a primary clinical indication for the use of vaginal slings, and its increasing prevalence is directly contributing to the market's expansion. Aging demographics, higher obesity rates, and post-childbirth complications are among the most common factors driving the incidence of SUI. Postmenopausal hormonal changes further weaken pelvic support structures, increasing the need for intervention. An industry study reveals that 13% of women who underwent urodynamic testing had their diagnosis revised to urodynamic stress incontinence, leading to changes in their treatment strategies, highlighting the critical role of accurate diagnostics and effective treatment options like vaginal slings. As more healthcare systems globally shift toward early screening and diagnosis, more women are being identified for potential surgical treatment, including sling procedures. Increased awareness and destigmatization of urinary incontinence, especially in urban and semi-urban settings, has also prompted a rise in patient consultations. This is supported by clinical guidelines that now more readily recommend slings as a first-line surgical option for moderate-to-severe cases, especially when conservative management fails.

Increase in Hysterectomy Rates and Post-Surgical Complications

The global rise in hysterectomy procedures, particularly in women, is contributing to the vaginal slings market growth. According to an industry report, about 3.3% women between the ages of 15 and 49 have undergone a hysterectomy. Post-hysterectomy patients often experience pelvic organ prolapse or bladder dysfunction due to the removal of uterine support structures. These complications can result in stress urinary incontinence, making slings a preferred solution for restoring continence. In certain regions, notably parts of Asia-Pacific and Latin America, hysterectomy is still commonly performed for conditions such as fibroids, chronic pelvic pain, and endometriosis, sometimes at earlier-than-necessary stages due to limited access to conservative alternatives. This creates a downstream effect, such as increased surgical interventions to manage incontinence symptoms. Hospitals and outpatient surgical centers are seeing more referrals for pelvic floor repair procedures. Urologists and gynecologic surgeons often include sling implantation during or after hysterectomy if incontinence is anticipated. This procedural bundling and proactive approach to pelvic health contribute to steady growth in sling adoption.

Technological Advancements and Mini-Sling Innovations

Technological improvements in sling design and materials have had a measurable impact on adoption rates. This trend is positively impacting the vaginal slings market outlook. Traditional mid-urethral slings required longer recovery times and were associated with certain risks, such as mesh erosion or post-operative voiding difficulties. Newer mini-slings and single-incision systems are changing that. These devices offer shorter operative times, less post-operative pain, and lower risk of complications, making them especially suitable for outpatient and day-care surgical settings. Research study published in June 2925 reported on the Contasure-Needleless(R) (C-NDL) mini-sling for stress urinary incontinence in women. Short-term results (six-month follow-up) showed high subjective cure rates, with over 54.17 of patients reporting they were "much" or "very much" better, and significant improvements in incontinence severity scores, with minimal complications observed. The study concludes that C-NDL mini-sling is a safe and effective minimally invasive option for managing stress urinary incontinence in the short term. Furthermore, better fixation mechanisms and tension-free designs have helped reduce procedural variability and improve long-term outcomes. Training programs for surgeons have also expanded to cover these newer technologies, increasing their usage across urology and urogynecology departments. Besides, the emergence of robotic-assisted and image-guided sling placement techniques in certain markets further illustrates how innovation continues to push procedural efficiency and patient safety.

VAGINAL SLINGS INDUSTRY SEGMENTATION:

Analysis by Type:

  • Conventional Vaginal Slings
  • Advanced Vaginal Slings

Conventional vaginal slings lead the market in 2025 due to their clinical use and proven efficacy in stress urinary incontinence management. These slings made from synthetic mesh or autologous tissue, are implanted by surgery for the support of the urethra and the bladder neck. Their well-documented safety record and broad acceptance by urologists and gynecologists are reasons why they remain the preferred choice, especially in situations that call for long-lasting, durable results. Conventional slings are particularly applicable in situations where experience with the procedure and standard surgical protocols are at a premium. With the growing interest in newer and more minimalistic approaches, traditional vaginal slings remain a tried-and-tested solution, especially in patients with intricate anatomical issues or prior failed surgeries. Their dominance is further reinforced by the availability of reimbursement in many healthcare systems, making them accessible to a broad patient population. With clinical outcomes continuing to confirm their effectiveness, they hold a consistent market share.

Analysis by Product Type:

  • Transobturator Slings
  • Tension-free Vaginal Tape Sling
  • Others

Transobturator slings leads the market with around 38.1% of market share in 2025. These slings are minimally invasive and possess a lower risk of bladder or bowel injury than retropubic methods. Specifically created to be inserted through the obturator foramen, these slings provide beneficial support to the urethra with fewer complications and quicker return to normal function. Their increasing popularity is both an indication of surgeon preference and demand by patients for procedures with decreased postoperative pain and quicker return to normal activity. Transobturator slings are especially popular in outpatient conditions, which has helped increase their percentage of the overall market. Clinical studies have repeatedly shown positive results, validating their application in the treatment of stress urinary incontinence. With improvement in surgical methods and materials, these slings are fast becoming a standard of care in primary repairs as well as in specifically selected reoperations. Their safety, effectiveness, and ease of insertion guarantee ongoing utility in diverse clinical practices.

Analysis by Type of Urinary Incontinence:

  • Stress Urinary Incontinence
  • Urge Urinary Incontinence
  • Mixed Urinary Incontinence

Stress urinary incontinence leads the market with around 41.2% of market share in 2025. The segment is responsible for a vast majority of procedures conducted worldwide. Characterized by the sudden leakage of urine with activities like coughing, sneezing, or exercise, SUI impacts quality of life considerably, particularly among middle-aged and elderly women. Vaginal slings are the commonly adopted surgical treatment for moderate to severe SUI, providing durable and effective relief from symptoms. Incidence of SUI is on the rise with the growing aging population, lifestyle changes, and childbirth-related pelvic floor injuries, all of which result in increased treatment rates. The excellent clinical outcomes and long history of use of sling procedures for SUI have established them as a staple in both urologic and gynecologic surgical practices. As the awareness and access to specialist care in developing nations increase, the rate of treatment for SUI is likely to increase, maintaining its relevance in the market.

Analysis by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Hospitals lead the market with around 48.7% of market share in 2025. This segment is the main site for diagnosis, surgical procedure, and postoperative treatment of urinary incontinence. Hospitals are well-equipped with sophisticated surgical facilities and highly trained specialists who are preferable for both open and minimally invasive sling surgeries. They manage a greater number of patients with complicated cases and are typically the initial point of care for individuals requiring assessment and treatment of stress urinary incontinence. Hospitals also gain from greater access to an assortment of sling devices, sustained by institutional procurement infrastructures and reimbursement policies. Their ability to address surgical complications and deliver complex patient care sustains the preference for hospital-based interventions. In both industrialized and developing countries, hospitals continue to be crucial to patient access and are important factors in training surgeons, assessing new procedures, and conducting clinical studies. Their controlling position in the end-user market guarantees a significant impact on product demand and adoption patterns.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 42.0%. The region has a well-established healthcare infrastructure, high awareness levels of urinary incontinence, and prevalent use of sophisticated surgical methods. Moreover, the market in the region is driven by a large pool of trained urologists and gynecologists, as well as the availability of a vast number of FDA-approved sling products. Beneficial reimbursement practices and regular screening habits lead to prompt diagnosis and increased treatment rates, particularly in the elderly female population. Besides, local efforts in research and development (R&D) also promote innovation in sling design, materials, and surgical techniques. The presence of specialized urogynecology clinics and outpatient surgical centers also enables higher procedure volumes. Although issues regarding complications from mesh have affected regulatory control and patient attitudes, overall demand for effective incontinence treatment is strong. North America continues to drive global market trends through clinical trials, adoption of new technology, and patient education programs.

KEY REGIONAL TAKEAWAYS:

UNITED STATES VAGINAL SLINGS MARKET ANALYSIS

The market in the United States is witnessing steady growth due to the increasing number of outpatient surgeries and advancements in minimally invasive procedures. The strong presence of technologically advanced healthcare facilities and widespread insurance coverage are promoting the adoption of vaginal slings. According to an industry report, nearly one-quarter of women in the U.S. experience pelvic floor disorders, including urinary incontinence and pelvic organ prolapse, which significantly drives demand for surgical intervention. Furthermore, growing awareness among the female population regarding early intervention for pelvic floor disorders has led to a rise in diagnostic rates and treatment uptake. The availability of specialized urogynecology centers and a robust clinical research ecosystem is fostering innovation in sling design and surgical techniques. In addition, the rising focus on postpartum pelvic health and the increasing involvement of women in physically demanding lifestyles are contributing to the demand for long-term solutions like vaginal slings. Digital health platforms that offer educational resources and teleconsultation services are also helping to bridge knowledge gaps and support informed treatment decisions. Favorable regulatory frameworks and expedited approval processes continue to enable the timely introduction of new sling technologies into the market.

EUROPE VAGINAL SLINGS MARKET ANALYSIS

In Europe, the vaginal slings market is expanding due to growing emphasis on quality of life and functional recovery following pelvic floor surgeries. The region's aging demographic is a significant driver, with a rising number of elderly women seeking surgical management for stress urinary incontinence. The Urology Foundation notes that the NHS estimates approximately 14 Million individuals in the UK are living with bladder problems, about 1 in 5 people, demonstrating a large potential patient base for sling-related procedures. Additionally, the integration of pelvic health into national public health agendas has amplified access to surgical treatments. The region benefits from a collaborative research environment that promotes clinical innovation and evidence-based practices. Healthcare infrastructure investments, particularly in surgical training programs, are improving procedural success rates and patient outcomes. Day-care surgical models, supported by efficient reimbursement structures, are increasing procedure volumes. Public awareness campaigns and advanced sling materials enhance biocompatibility and surgical acceptance.

ASIA-PACIFIC VAGINAL SLINGS MARKET ANALYSIS

The vaginal slings market in Asia-Pacific is growing rapidly owing to increased urbanization and rising healthcare expenditure. A significant factor contributing to this growth is the expanding middle-class population with better access to specialized healthcare services. According to reports, the prevalence of at least one pelvic floor dysfunction among women in India stands at 23.7%, while 2.9% experience pelvic organ prolapse, indicating both treatment needs and potential underdiagnosis. Lifestyle changes and growing awareness about pelvic health issues are leading more women to seek medical treatment for incontinence and prolapse. The proliferation of private hospital chains and specialty clinics is improving the availability of urogynecological procedures. Additionally, government-led initiatives promoting women's health and wellness are enhancing early diagnosis and intervention rates. The rise in medical tourism in the region is boosting the use of advanced pelvic floor surgeries, with increased collaboration between healthcare providers and global technology firms promoting modern surgical techniques.

LATIN AMERICA VAGINAL SLINGS MARKET ANALYSIS

In Latin America, the market is gaining traction due to growing patient awareness and evolving healthcare delivery systems. The Organization for Economic Cooperation and Development (OECD) states that Brazil's Unified Health System (SUS) accounts for 42% of overall health spending, creating a substantial public-sector opportunity for women's health procedures. Expansion of health insurance coverage in urban centers is making surgical solutions like vaginal slings more financially accessible to a larger population. In parallel, improved physician training and access to specialized medical education are contributing to enhanced procedural expertise. Public-private partnerships are playing a key role in modernizing healthcare facilities, which supports the integration of advanced pelvic floor surgical options. Additionally, shifting cultural perceptions around women's health and proactive wellness practices are driving early medical consultations and increasing demand for curative treatments such as slings.

MIDDLE EAST AND AFRICA VAGINAL SLINGS MARKET ANALYSIS

The market in the Middle East and Africa is experiencing gradual growth, supported by rising investments in women's health services. The Saudi Arabian government plans to raise the private sector's share of healthcare from 40% to 65% by 2030. This initiative includes the privatization of 290 hospitals and 2,300 primary healthcare centers. The expansion of private healthcare networks and the establishment of specialty clinics are increasing access to pelvic floor treatments. Awareness programs focusing on maternal health and aging-related conditions are encouraging more women to seek surgical interventions. Technological advancements introduced through international collaborations facilitate the use of modern sling systems. Furthermore, the growing presence of trained surgical professionals in metropolitan areas enhances procedural confidence, thereby expanding the patient base for vaginal sling procedures in the region.

COMPETITIVE LANDSCAPE:

The market is characterized by a mix of established and emerging players offering a range of synthetic and biological options. Moreover, surgical methods continue to shift, with a growing interest in minimally invasive procedures. Also, the market demand is heavily influenced by the increasing number of women experiencing stress urinary incontinence and greater awareness about treatment options. Besides, safety concerns and regulatory scrutiny over mesh-based products have led to a rise in demand for alternatives, affecting product development and adoption rates. Apart from this, pricing pressure from regional players and the need for clinical validation also contribute to competitive intensity. According to the vaginal slings market forecast, the market is projected to grow steadily over the next few years, propelled by an aging female population, wider healthcare access in developing regions, and ongoing improvements in sling design and surgical outcomes. Furthermore, competition will likely sharpen as companies race to introduce safer, more effective materials and strengthen distribution across hospitals, specialty clinics, and ambulatory surgical centers.

The report provides a comprehensive analysis of the competitive landscape in the vaginal slings market with detailed profiles of all major companies, including:

  • A.M.I. GmbH
  • B. Braun SE
  • Betatech Medical
  • Boston Scientific Corporation
  • Caldera Medical
  • Coloplast Corp
  • Cousin Surgery
  • Promedon GmbH
  • UroCure

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the vaginal slings market?

2. What is the future outlook of the vaginal slings market?

3. What are the key factors driving the vaginal slings market?

4. Which region accounts for the largest vaginal slings market?

5. Which are the leading companies in the global vaginal slings market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Vaginal Slings Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Conventional Vaginal Slings
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Advanced Vaginal Slings
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Transobturator Slings
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tension-free Vaginal Tape Sling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Type of Urinary Incontinence

  • 8.1 Stress Urinary Incontinence
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Urge Urinary Incontinence
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Mixed Urinary Incontinence
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgery Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 A.M.I. GmbH
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 B. Braun SE
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Betatech Medical
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Boston Scientific Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Caldera Medical
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Coloplast Corp
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Cousin Surgery
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Promedon GmbH
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 UroCure
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Vaginal Slings Market: Major Drivers and Challenges
  • Figure 2: Global: Vaginal Slings Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Vaginal Slings Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Vaginal Slings Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Vaginal Slings Market: Breakup by Product Type (in %), 2025
  • Figure 6: Global: Vaginal Slings Market: Breakup by Type of Urinary Incontinence (in %), 2025
  • Figure 7: Global: Vaginal Slings Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Vaginal Slings Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Vaginal Slings (Conventional Vaginal Slings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Vaginal Slings (Conventional Vaginal Slings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Vaginal Slings (Advanced Vaginal Slings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Vaginal Slings (Advanced Vaginal Slings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Vaginal Slings (Transobturator Slings) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Vaginal Slings (Transobturator Slings) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Vaginal Slings (Tension-free Vaginal Tape Sling) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Vaginal Slings (Tension-free Vaginal Tape Sling) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Vaginal Slings (Other Product Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Vaginal Slings (Other Product Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Vaginal Slings (Stress Urinary Incontinence) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Vaginal Slings (Stress Urinary Incontinence) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Vaginal Slings (Urge Urinary Incontinence) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Vaginal Slings (Urge Urinary Incontinence) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Vaginal Slings (Mixed Urinary Incontinence) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Vaginal Slings (Mixed Urinary Incontinence) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Vaginal Slings (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Vaginal Slings (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Vaginal Slings (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Vaginal Slings (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Vaginal Slings (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Vaginal Slings (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia-Pacific: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia-Pacific: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Vaginal Slings Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Vaginal Slings Market: Breakup by Country (in %), 2025
  • Figure 79: Middle East and Africa: Vaginal Slings Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: Global: Vaginal Slings Industry: SWOT Analysis
  • Figure 81: Global: Vaginal Slings Industry: Value Chain Analysis
  • Figure 82: Global: Vaginal Slings Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Vaginal Slings Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Vaginal Slings Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Vaginal Slings Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 4: Global: Vaginal Slings Market Forecast: Breakup by Type of Urinary Incontinence (in Million USD), 2026-2034
  • Table 5: Global: Vaginal Slings Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Vaginal Slings Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Vaginal Slings Market: Competitive Structure
  • Table 8: Global: Vaginal Slings Market: Key Players